Iron-Biofortified Beans Intervention in Mexico

Not Applicable

Completed

• Conditions: Anemia; Iron-deficiency
• Interventions: Other: Control beans; Other: Iron-biofortified beans

• Registration Number: NCT03835377
• Lead Sponsor: Cornell University

Brief Summary

The objective of this cluster-randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified beans (Fe-Beans) on iron status in children, compared to control beans (Control-Beans). A cluster-randomized trial of biofortified beans (Phaseolus vulgaris L), bred to enhance iron content, was conducted for 6 months.

Detailed Description

Iron deficiency is the most common single nutrient deficiency worldwide, with the highest burden in children and women of reproductive age. Global estimates of anemia prevalence in school-aged children range between 25% and 46%, and iron deficiency accounts for a majority of anemia cases. In Mexico, the national nutrition and health survey (2006) reported a prevalence of anemia of 16.6% and iron deficiency of 17.6% (serum ferritin \<12.0 µg/L), posing a considerable health risk for children.

Interventions, including micronutrient supplementation and food fortification, have improved iron status and reduced the prevalence of anemia in some settings. However, iron deficiency remains an urgent public health problem and threat to child health and development. Young children are particularly at high risk due to rapid growth, inadequate dietary intake, and high risk of infection in resource-limited settings. Iron deficiency has been associated with impaired cognitive function in children, and long-term impairments in physical work capacity into adulthood.

One novel approach to reducing micronutrient malnutrition is to enhance the nutrient quality of the diet through biofortification of staple crops that are already locally accepted and consumed. Biofortification has consequently been recognized by the Copenhagen Consensus of 2008 as one of the top five solutions to current global health and nutrition challenges. The success and challenges of biofortification have been documented previously. We recently reviewed the published evidence from the three randomized efficacy trials of different iron-biofortified crops that demonstrated varied benefits in populations, including rice in adult Filipino women, pearl millet in school-aged children in India, and beans in women of reproductive age in Rwanda. Findings demonstrated improvements in serum ferritin concentrations and total body iron concentrations, with additional potential to benefit in individuals who were iron deficient at baseline. Given this limited evidence and with no studies from Latin America, more studies with diverse populations and locally relevant crops are warranted before implementation of a potentially important public health intervention.

In order to target at-risk populations in Latin America, the Centro Internacional de Agricultura Tropical (CIAT) in Colombia bred and biofortified a common black bean variety (Phaseolus vulgaris L), the standard black bean currently consumed widely in Central America and Mexico. In Mexico, beans have been ranked highly among the most consumed foods by school-aged children nationwide, according to Encuesta Nacional de Salud y Nutrición, a nationally representative nutrition survey in 2006. Biofortification has nearly doubled the iron concentration (\~100 versus \~50 mg/kg) of the standard bean variety. We hypothesized that daily consumption of iron-biofortified beans (Fe-Beans) would improve hemoglobin, serum ferritin, and total body iron in 6 months, compared to control beans (Control-Beans). In order to examine this hypothesis, we conducted the first randomized efficacy trial of iron-biofortified beans and iron status in primary school-aged children in a low-income setting in Mexico. Special consideration was applied to assess indicators of iron status with and without anemia and measured inflammatory markers, which can mask iron deficiency, particularly in similar settings where the prevalence of infection is high.

The objective of this cluster-randomized efficacy feeding trial was to determine the effects of consuming iron-biofortified beans (Fe-Beans) on iron status in children, compared to control beans (Control-Beans).

The long-term goal of this study is to determine if iron bio-fortification of beans is an efficacious and potentially effective strategy to improve iron status of at-risk populations in resource-limited settings.

Study Timeline

• Study Start: 2010-01-06
• Primary Completion: 2010-06-25
• Study Completion: 2010-08-15
• Study First Submitted: 2019-01-11
• Status Verified: 2019-02
• Study First Submitted QC: 2019-02-07
• Study First Posted: 2019-02-08
• Last Update Submitted: 2019-02-18
• Last Update Posted: 2019-02-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 574

Inclusion Criteria

Not provided

Exclusion Criteria

• A prevalence of anemia <15.0% on the baseline survey
• Inadequate infrastructure to sustain a 6-month feeding trial

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control beans	Control beans	Control beans (Phaseolus vulgaris L Jamapa variety)
Iron-biofortified beans	Iron-biofortified beans	Iron-biofortified beans (Phaseolus vulgaris L MIB465)

Primary Outcome Measures

Name	Time	Method
Change in serum ferritin	6 months	Serum ferritin (SF)
Anemia	6 months	Hb \<115 g/L for \<12 y; \<120 g/L for \>=12 y
Change in sTfR	6 months	Soluble transferrin receptor (sTfR)
Iron deficiency (SF)	6 months	Serum ferritin \<15.0 µg/L
Change in hemoglobin	6 months	Hemoglobin (Hb)

Secondary Outcome Measures

Name	Time	Method
Iron deficiency (sTfr)	6 months	sTfr \>8.3 μg/mL
Iron deficiency (TBI)	6 months	TBI \<0.0 mg/kg
Change in TBI	6 months	Total body iron (TBI)

Trial Locations

Locations (1)

Instituto Nacional de Salud Publica (INSP); 🇲🇽 Cuernavaca, Morelos, Mexico